ConductScience.org, home

Paper42860281PubMed

Clinical evaluation and treatment of obesity in women across selected life stages: a narrative review.

Lee Y and 1 other. Womens Health Nurs, 2026.

Cite this record

ConductScience Library. Clinical evaluation and treatment of obesity in women across selected life stages: a narrative review. Papers, record 42860281. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42860281

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical evaluation and treatment of obesity in women across selected life stages: a narrative review.
Journal
Womens Health Nurs
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-14

Source PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee YYongho
2Oh BBumjo

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ObesityMajor topic
Humans
Female
Polycystic Ovary Syndrome
Menopause
Body Mass Index

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128538730Blocking FSH induces thermogenic adipose tissue and reduces body fat.Nature2017https://conductscience.org/library/papers/28538730PubMed
232753461Obesity in adults: a clinical practice guideline.CMAJ2020https://conductscience.org/library/papers/32753461PubMed
338536037Effects of follicle-stimulating hormone on energy balance and tissue metabolic health after loss of ovarian function.Am J Physiol Endocrinol Metab2024https://conductscience.org/library/papers/38536037PubMed
430785613Addressing Medicine's Bias Against Patients Who Are Overweight.JAMA2019https://conductscience.org/library/papers/30785613PubMed
537580314Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.J Clin Endocrinol Metab2023https://conductscience.org/library/papers/37580314PubMed
622029981Long-term persistence of hormonal adaptations to weight loss.N Engl J Med2011https://conductscience.org/library/papers/22029981PubMed
727188659Menopause.Nat Rev Dis Primers2015https://conductscience.org/library/papers/27188659PubMed
828617414Obesity.Nat Rev Dis Primers2017https://conductscience.org/library/papers/28617414PubMed
935658024Tirzepatide Once Weekly for the Treatment of Obesity.N Engl J Med2022https://conductscience.org/library/papers/35658024PubMed
1025752756Impact of weight bias and stigma on quality of care and outcomes for patients with obesity.Obes Rev2015https://conductscience.org/library/papers/25752756PubMed
1122618581Shared decision making: a model for clinical practice.J Gen Intern Med2012https://conductscience.org/library/papers/22618581PubMed
1219188927A proposed clinical staging system for obesity.Int J Obes (Lond)2009https://conductscience.org/library/papers/19188927PubMed
1334156162Selection of antiobesity medications based on phenotypes enhances weight loss: A pragmatic trial in an obesity clinic.Obesity (Silver Spring)2021https://conductscience.org/library/papers/34156162PubMed
1433567185Once-Weekly Semaglutide in Adults with Overweight or Obesity.N Engl J Med2021https://conductscience.org/library/papers/33567185PubMed
1511234459Obesity: preventing and managing the global epidemic. Report of a WHO consultation.World Health Organ Tech Rep Ser2000https://conductscience.org/library/papers/11234459PubMed
1638446869Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use.Menopause2024https://conductscience.org/library/papers/38446869PubMed
1735797481The 2022 hormone therapy position statement of The North American Menopause Society.Menopause2022https://conductscience.org/library/papers/35797481PubMed
1839824205Definition and diagnostic criteria of clinical obesity.Lancet Diabetes Endocrinol2025https://conductscience.org/library/papers/39824205PubMed
1936945077Evaluation and Treatment of Obesity and Its Comorbidities: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity.J Obes Metab Syndr2023https://conductscience.org/library/papers/36945077PubMed
2033759389Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic.Obesity (Silver Spring)2021https://conductscience.org/library/papers/33759389PubMed

See all 25 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42860281

GET https://conductscience.org/api/papers/v1/42860281/references?page=2